Sirona Medical, Inc. is a technology company that has developed a cloud-native diagnostic engine tailored for radiologists. Founded in 2018 and headquartered in San Francisco, California, Sirona aims to revolutionize the field of radiology by providing a unified platform that integrates various essential tools, including a universal worklist, viewer, reporter, and AI capabilities. This innovative system simplifies complex workflows, enhances productivity, and allows practitioners to focus on patient care rather than administrative tasks. By streamlining operations and incorporating advanced AI technologies, Sirona empowers radiologists to work more efficiently and effectively, enabling them to deliver better and faster healthcare services.
Surglogs
Venture Round in 2024
SurgLogs Inc. is a software developer based in San Diego, California, specializing in compliance-related solutions for ambulatory surgery centers and healthcare facilities. Founded in 2015, the company provides a digital platform that replaces traditional pen-and-paper methods with a HIPAA-compliant application and an administrative dashboard. This platform organizes and automates the management of logbooks, medications, supplies, in-services, and drills, enhancing efficiency and reducing paperwork for healthcare organizations. SurgLogs offers features such as device authorization, automated daily checks and notifications, and electronic report export services, catering to doctors, nurses, and healthcare administrators. By streamlining compliance processes, SurgLogs enables its clients to maintain regulatory standards effectively and manage operations more efficiently.
Even is a health tech company that provides comprehensive health coverage services through a subscription model. By partnering with leading hospitals, it offers unlimited access to diagnostics, consultations, and substantial hospitalization coverage for a fixed monthly fee. Even streamlines the healthcare experience with a claimless reimbursement process, directly transferring funds to partner hospitals on behalf of its members. This approach allows individuals to efficiently address their long-term health needs while simplifying the often complex healthcare payment process.
Candid Health
Series B in 2024
Candid Health is a developer of an innovative platform that automates the revenue cycle management process for healthcare providers. By utilizing machine learning and artificial intelligence, Candid Health streamlines essential tasks such as medical billing, coding, and claims processing. The platform is designed for seamless integration with existing healthcare infrastructure, allowing providers to efficiently manage the complexities of medical billing. This automation reduces administrative burdens and enhances operational efficiency, enabling healthcare facilities to focus on delivering high-quality, affordable, and accessible care to patients. Candid Health's end-to-end solution also aims to improve the overall patient experience by ensuring faster reimbursement and better management of financial operations.
Even
Venture Round in 2024
Even is a health tech company that provides comprehensive health coverage services through a subscription model. By partnering with leading hospitals, it offers unlimited access to diagnostics, consultations, and substantial hospitalization coverage for a fixed monthly fee. Even streamlines the healthcare experience with a claimless reimbursement process, directly transferring funds to partner hospitals on behalf of its members. This approach allows individuals to efficiently address their long-term health needs while simplifying the often complex healthcare payment process.
Hopscotch Primary Care
Series C in 2024
Operator of a data-driven healthcare startup intended to transform healthcare in rural communities through exceptional care, bringing better access and quality service to its patients. The company delivers tailored quality care through a team-based model, with resources and support for patients, inside and outside clinics, thereby enabling healthcare professionals to provide the support and care that patients need.
Oula Health
Series B in 2024
Oula Health, Inc. is a maternity care provider based in Brooklyn, New York, established in 2019. The company focuses on redesigning maternity care by integrating obstetrics and midwifery to create a personalized and evidence-based experience for expecting families. Oula operates clinics and offers home-based prenatal care services, aiming to set a new standard for pregnancy care that harmonizes modern medical practices with a compassionate approach. Through its innovative model, Oula Health seeks to enhance the overall maternity care experience for its clients.
Vital Bio
Venture Round in 2023
Vital Bio is focused on transforming lab testing to make healthcare more accessible and personalized. The company develops advanced diagnostic technologies that integrate devices, software, and services to support patients in monitoring their health and managing diseases. By bridging the gap between diagnosis and treatment, Vital Bio aims to empower patients and healthcare providers alike, promoting proactive care and reducing disparities in health outcomes. The company's innovative approach seeks to enhance the overall healthcare experience, ensuring that individuals have greater control over their health management.
Empassion
Venture Round in 2023
Empassion Health is a company that specializes in comprehensive, community-based care for patients experiencing advanced illnesses. Founded in 2022, the company provides essential tools for managing patient care across various stages, including enrollment, care management, and coordination. Its services encompass primary and urgent care visits, goals planning, and social and spiritual care planning. Empassion Health aims to enhance the quality of life for patients, allowing them to maintain their well-being and independence in the comfort of their homes.
Oula Health
Series A in 2023
Oula Health, Inc. is a maternity care provider based in Brooklyn, New York, established in 2019. The company focuses on redesigning maternity care by integrating obstetrics and midwifery to create a personalized and evidence-based experience for expecting families. Oula operates clinics and offers home-based prenatal care services, aiming to set a new standard for pregnancy care that harmonizes modern medical practices with a compassionate approach. Through its innovative model, Oula Health seeks to enhance the overall maternity care experience for its clients.
Nimbus Health
Seed Round in 2022
Our mission is to redefine the standard of care in pulmonary medicine and deliver the best lung care in America. We’re rebuilding the pulmonary clinic around a technology platform and a set of virtual and physical interventions calibrated to keep lung conditions under control. At a Nimbus Clinic, rich patient data and predictive models allow our providers to make more thoughtful medical decisions, and step in at exactly the right moment.
Digital Diagnostics
Series B in 2022
Digital Diagnostics Inc. is an artificial intelligence diagnostics company focused on enhancing healthcare through technology. Founded in 2010 by Michael Abramoff, MD, PhD, the company has developed a suite of autonomous algorithms that analyze medical images to detect various diseases. Its flagship products include IDx-DR, which identifies diabetic retinopathy; IDx-G, which monitors glaucoma indicators; and IDx-AMD, designed to detect age-related macular degeneration. The company also offers algorithms for diagnosing conditions such as Alzheimer's disease, cardiovascular disease, and stroke risk. By providing these innovative solutions, Digital Diagnostics aims to improve the quality, accessibility, equity, and affordability of healthcare worldwide. Operating from Coralville, Iowa, the company distributes its products both domestically and internationally, striving to integrate autonomous AI into standard clinical practices and enhance patient outcomes.
KeyCare is a virtual care platform that leverages the Epic system to support health systems in enhancing patient access and quality of care. The platform is designed to provide a tech-driven virtual care team that supplements existing healthcare workforces, thereby broadening the options available for virtual care. By focusing on increasing accessibility and improving care quality, KeyCare aims to meet the needs of patients and healthcare providers in a rapidly evolving healthcare landscape.
Candid Health
Series A in 2022
Candid Health is a developer of an innovative platform that automates the revenue cycle management process for healthcare providers. By utilizing machine learning and artificial intelligence, Candid Health streamlines essential tasks such as medical billing, coding, and claims processing. The platform is designed for seamless integration with existing healthcare infrastructure, allowing providers to efficiently manage the complexities of medical billing. This automation reduces administrative burdens and enhances operational efficiency, enabling healthcare facilities to focus on delivering high-quality, affordable, and accessible care to patients. Candid Health's end-to-end solution also aims to improve the overall patient experience by ensuring faster reimbursement and better management of financial operations.
Cellino is focused on developing a scalable, automated biomanufacturing system aimed at producing personalized cell therapies. The company's innovative platform leverages AI-guided laser editing to generate autologous induced pluripotent stem cells (iPSCs) efficiently and at scale. By utilizing image-guided machine learning, single-cell laser processing, and robotics, Cellino seeks to make advanced, potentially curative treatments accessible for a range of chronic degenerative diseases, including vision loss and Parkinson's disease. The company's mission is to transform healthcare by enabling personalized therapies that can significantly improve patient outcomes and overall health.
Ritten
Venture Round in 2022
Ritten is a company that provides an electronic medical records platform specifically designed for addiction treatment providers. Its platform enhances the quality of care by allowing clinicians and administrators to deliver personalized, data-informed treatment. Ritten's solution features customizable workflow configurations, which facilitate the consistent and compliant delivery of complex treatment. The platform enables healthcare professionals to maintain comprehensive patient records that encompass all dimensions of care, including clinical notes, medications, and treatment plans. Through its innovative approach, Ritten aims to improve outcomes for patients in addiction treatment settings.
Pair Team
Seed Round in 2021
Pair Team is dedicated to enhancing primary care infrastructure for vulnerable communities, focusing on Medicaid and Medicare patients. As the first tech-enabled care team, they support safety-net primary care systems by acting as an extension of clinical staff, delivering personalized and high-touch care experiences. Their approach addresses various barriers to healthcare access, including transportation issues, housing and food insecurity, and limitations in mobile phone access. To facilitate effective care delivery, Pair Team is developing a unique platform that ensures adherence to clinical best practices, integrates services with community-based organizations, and automates administrative tasks, allowing clinicians to concentrate more on patient interaction. The company employs a diverse team of professionals, including community health workers, registered nurses, and behavioral health clinicians, to provide comprehensive support tailored to the needs of low-income individuals, thereby promoting a holistic and patient-centered care model.
SurgLogs Inc. is a software developer based in San Diego, California, specializing in compliance-related solutions for ambulatory surgery centers and healthcare facilities. Founded in 2015, the company provides a digital platform that replaces traditional pen-and-paper methods with a HIPAA-compliant application and an administrative dashboard. This platform organizes and automates the management of logbooks, medications, supplies, in-services, and drills, enhancing efficiency and reducing paperwork for healthcare organizations. SurgLogs offers features such as device authorization, automated daily checks and notifications, and electronic report export services, catering to doctors, nurses, and healthcare administrators. By streamlining compliance processes, SurgLogs enables its clients to maintain regulatory standards effectively and manage operations more efficiently.
Sirona Medical, Inc. is a technology company that has developed a cloud-native diagnostic engine tailored for radiologists. Founded in 2018 and headquartered in San Francisco, California, Sirona aims to revolutionize the field of radiology by providing a unified platform that integrates various essential tools, including a universal worklist, viewer, reporter, and AI capabilities. This innovative system simplifies complex workflows, enhances productivity, and allows practitioners to focus on patient care rather than administrative tasks. By streamlining operations and incorporating advanced AI technologies, Sirona empowers radiologists to work more efficiently and effectively, enabling them to deliver better and faster healthcare services.
Better Health
Series A in 2021
Better Health is a support and supplies platform that focuses on enhancing the management of chronic conditions such as ostomy, chronic wounds, diabetes, chronic retention, and incontinence through peer-to-peer connections. The company provides expert guidance to help patients select and use the appropriate medical supplies for their needs. By delivering peer support and educational resources, Better Health aims to improve patient engagement and adherence, ultimately leading to better health outcomes and reduced healthcare costs. Trusted by various healthcare payers and providers, the company operates in 48 states and has achieved a 98% customer satisfaction rating. Co-founded by Naama Stauber Breckler and Adam Breckler, Better Health is committed to modernizing the medical supplies industry and enhancing the overall patient experience.
Examedi
Seed Round in 2021
Examedi is a healthcare startup that facilitates at-home medical services by connecting patients with independent healthcare providers, including nurses and lab technicians. The company's telemedicine platform allows patients to book diagnostic tests and examinations from the comfort of their homes, focusing on services such as blood tests, pregnancy tests, general check-ups, and COVID-19 testing. By streamlining the scheduling process and offering affordable access to various medical tests, Examedi aims to enhance patient convenience and improve healthcare delivery.
Maximus
Seed Round in 2021
Maximus is a consumer telemedicine company for men’s health and hormone optimization. Maximus is revolutionizing the performance enhancement space by democratizing doctor-prescribed protocols developed by some of the world’s leading experts in men’s health. Maximus’ King Protocol utilizes a convenient prescription medication capsule to stimulate natural testosterone production, proven by at-home lab tests. Maximus was established in 2020 by Cameron Sepah in Santa Monica, California.
Cityblock
Series C in 2021
Cityblock Health, Inc., established in 2017 and headquartered in Brooklyn, New York, operates a personalized health system tailored to meet the unmet health and social needs of Medicaid and Medicare populations. The company's online platform offers integrated primary care, behavioral health, and virtual care services, along with a tool called Commons for communication, information sharing, and task management. Cityblock's model focuses on upstream investment in highly personalized, prevention-oriented care, aiming to improve outcomes and reduce costs. It partners with community-based organizations to deliver care, enabling clinicians to provide personalized care for each member. During the COVID-19 pandemic, Cityblock developed a model to help identify high-risk members within organizations.
Better Health
Seed Round in 2021
Better Health is a support and supplies platform that focuses on enhancing the management of chronic conditions such as ostomy, chronic wounds, diabetes, chronic retention, and incontinence through peer-to-peer connections. The company provides expert guidance to help patients select and use the appropriate medical supplies for their needs. By delivering peer support and educational resources, Better Health aims to improve patient engagement and adherence, ultimately leading to better health outcomes and reduced healthcare costs. Trusted by various healthcare payers and providers, the company operates in 48 states and has achieved a 98% customer satisfaction rating. Co-founded by Naama Stauber Breckler and Adam Breckler, Better Health is committed to modernizing the medical supplies industry and enhancing the overall patient experience.
Cellino
Seed Round in 2021
Cellino is focused on developing a scalable, automated biomanufacturing system aimed at producing personalized cell therapies. The company's innovative platform leverages AI-guided laser editing to generate autologous induced pluripotent stem cells (iPSCs) efficiently and at scale. By utilizing image-guided machine learning, single-cell laser processing, and robotics, Cellino seeks to make advanced, potentially curative treatments accessible for a range of chronic degenerative diseases, including vision loss and Parkinson's disease. The company's mission is to transform healthcare by enabling personalized therapies that can significantly improve patient outcomes and overall health.
SummerBio
Venture Round in 2020
SummerBio LLC is an automation-based diagnostics company focused on providing rapid and affordable COVID-19 testing services. Founded in 2020 and based in Menlo Park, California, the company has developed an end-to-end testing system that automates the gold-standard RT-qPCR testing regimen. Utilizing advanced technologies such as state-of-the-art robotics and automated liquid handling systems, SummerBio offers a novel sample collection kit designed for high-volume testing. The company's services enable healthcare professionals and patients to receive COVID-19 test results within a day, positioning it as a key player in the diagnostics sector amidst the ongoing pandemic. SummerBio operates a CLIA-certified laboratory to facilitate these testing services.
Avail Medsystems
Series B in 2020
Avail Medsystems, Inc. is a digital healthcare company based in Palo Alto, California, that specializes in developing a comprehensive hardware and software platform designed to connect healthcare professionals remotely. The company offers a fully integrated audio/visual system that facilitates real-time collaboration and procedural support, enabling practitioners to access clinical expertise and education without the constraints of physical location. By democratizing access to specialized knowledge and services, Avail Medsystems enhances the efficiency of healthcare delivery and promotes the adoption of innovative medical technologies. Founded in 2012 and previously known as Nurep, Inc., the company aims to improve patient care by bridging gaps between healthcare providers and medical technology experts.
Sirona Medical, Inc. is a technology company that has developed a cloud-native diagnostic engine tailored for radiologists. Founded in 2018 and headquartered in San Francisco, California, Sirona aims to revolutionize the field of radiology by providing a unified platform that integrates various essential tools, including a universal worklist, viewer, reporter, and AI capabilities. This innovative system simplifies complex workflows, enhances productivity, and allows practitioners to focus on patient care rather than administrative tasks. By streamlining operations and incorporating advanced AI technologies, Sirona empowers radiologists to work more efficiently and effectively, enabling them to deliver better and faster healthcare services.
Cityblock
Series B in 2020
Cityblock Health, Inc., established in 2017 and headquartered in Brooklyn, New York, operates a personalized health system tailored to meet the unmet health and social needs of Medicaid and Medicare populations. The company's online platform offers integrated primary care, behavioral health, and virtual care services, along with a tool called Commons for communication, information sharing, and task management. Cityblock's model focuses on upstream investment in highly personalized, prevention-oriented care, aiming to improve outcomes and reduce costs. It partners with community-based organizations to deliver care, enabling clinicians to provide personalized care for each member. During the COVID-19 pandemic, Cityblock developed a model to help identify high-risk members within organizations.
Swiftscale Biologics
Seed Round in 2020
Swiftscale Biologics is a healthcare service provider based in South San Francisco, California, founded in 2019. The company specializes in cell-free protein synthesis, focusing on rapid expression, high-throughput synthesis, and the production of complex proteins. Its innovative platform is designed to test and develop antibodies that inhibit the interaction between viral proteins and human host cells, effectively stopping ongoing coronavirus infections. By advancing these life-saving drugs, Swiftscale Biologics aims to enhance patient outcomes and improve overall health.
Candid Health
Seed Round in 2020
Candid Health is a developer of an innovative platform that automates the revenue cycle management process for healthcare providers. By utilizing machine learning and artificial intelligence, Candid Health streamlines essential tasks such as medical billing, coding, and claims processing. The platform is designed for seamless integration with existing healthcare infrastructure, allowing providers to efficiently manage the complexities of medical billing. This automation reduces administrative burdens and enhances operational efficiency, enabling healthcare facilities to focus on delivering high-quality, affordable, and accessible care to patients. Candid Health's end-to-end solution also aims to improve the overall patient experience by ensuring faster reimbursement and better management of financial operations.
Surglogs
Venture Round in 2020
SurgLogs Inc. is a software developer based in San Diego, California, specializing in compliance-related solutions for ambulatory surgery centers and healthcare facilities. Founded in 2015, the company provides a digital platform that replaces traditional pen-and-paper methods with a HIPAA-compliant application and an administrative dashboard. This platform organizes and automates the management of logbooks, medications, supplies, in-services, and drills, enhancing efficiency and reducing paperwork for healthcare organizations. SurgLogs offers features such as device authorization, automated daily checks and notifications, and electronic report export services, catering to doctors, nurses, and healthcare administrators. By streamlining compliance processes, SurgLogs enables its clients to maintain regulatory standards effectively and manage operations more efficiently.
Nines is a pioneering teleradiology practice that focuses on enhancing patient care through advanced technology. The company develops in-house tools that empower radiologists to provide high-quality diagnostics. Its platform is designed to analyze medical scans for urgent findings that necessitate immediate attention, as well as to identify subtle details that assist in the radiological review process. This innovative approach aims to improve the accuracy of results and overall patient care, setting Nines apart in the field of radiology.
Swiftscale Biologics
Seed Round in 2019
Swiftscale Biologics is a healthcare service provider based in South San Francisco, California, founded in 2019. The company specializes in cell-free protein synthesis, focusing on rapid expression, high-throughput synthesis, and the production of complex proteins. Its innovative platform is designed to test and develop antibodies that inhibit the interaction between viral proteins and human host cells, effectively stopping ongoing coronavirus infections. By advancing these life-saving drugs, Swiftscale Biologics aims to enhance patient outcomes and improve overall health.
Cityblock
Series B in 2019
Cityblock Health, Inc., established in 2017 and headquartered in Brooklyn, New York, operates a personalized health system tailored to meet the unmet health and social needs of Medicaid and Medicare populations. The company's online platform offers integrated primary care, behavioral health, and virtual care services, along with a tool called Commons for communication, information sharing, and task management. Cityblock's model focuses on upstream investment in highly personalized, prevention-oriented care, aiming to improve outcomes and reduce costs. It partners with community-based organizations to deliver care, enabling clinicians to provide personalized care for each member. During the COVID-19 pandemic, Cityblock developed a model to help identify high-risk members within organizations.
Digital Diagnostics
Series A in 2018
Digital Diagnostics Inc. is an artificial intelligence diagnostics company focused on enhancing healthcare through technology. Founded in 2010 by Michael Abramoff, MD, PhD, the company has developed a suite of autonomous algorithms that analyze medical images to detect various diseases. Its flagship products include IDx-DR, which identifies diabetic retinopathy; IDx-G, which monitors glaucoma indicators; and IDx-AMD, designed to detect age-related macular degeneration. The company also offers algorithms for diagnosing conditions such as Alzheimer's disease, cardiovascular disease, and stroke risk. By providing these innovative solutions, Digital Diagnostics aims to improve the quality, accessibility, equity, and affordability of healthcare worldwide. Operating from Coralville, Iowa, the company distributes its products both domestically and internationally, striving to integrate autonomous AI into standard clinical practices and enhance patient outcomes.
Maven Clinic
Series B in 2018
Maven Clinic is an on-demand digital care clinic focused on supporting mothers and families during conception, pregnancy, and the postpartum period. Founded in 2014 and headquartered in New York City, the clinic provides video appointments and private messaging with a network of women's and family health practitioners. Its comprehensive services cater to various needs, including IVF and egg-freezing tracks, pregnancy, postpartum, partner support, adoption, surrogacy, and loss. Additionally, Maven Clinic offers career coaching, support, and customized training for human resources managers. The company serves individuals, employers, and healthcare professionals, aiming to enhance family health and well-being through accessible digital care solutions.
uBiome, Inc. was a microbial genomics company based in San Francisco, California, founded in 2012. It specialized in sequencing-based clinical microbiome tests, offering products such as SmartGut, a test for identifying pathogenic and commensal microorganisms related to infections, and SmartJane, a women's health screening test that detects various conditions including HPV and STIs. The company also provided Explorer kits for citizen scientists and researchers, as well as SmartFlu, a clinical respiratory test. By leveraging precision sequencing combined with machine learning and artificial intelligence, uBiome aimed to enhance the understanding of the human microbiome, enabling healthcare providers to deliver more accurate diagnoses and empowering patients to manage their health more effectively. However, uBiome faced financial difficulties and filed for Chapter 11 bankruptcy in September 2019, which was later converted to Chapter 7 on October 11, 2019.
Mammoth Biosciences
Series A in 2018
Mammoth Biosciences, Inc. is a biotechnology company based in South San Francisco, California, founded in 2017 by CRISPR pioneer Jennifer Doudna and other key innovators. The company specializes in developing advanced CRISPR technologies, including its proprietary DETECTR platform, which enables the rapid detection of specific nucleic acids associated with various diseases. This platform facilitates diagnostic applications such as cancer screening, bacterial infections, and viral infections, allowing for real-time and simultaneous testing of multiple conditions. In addition to diagnostics, Mammoth Biosciences works on genome editing solutions for therapeutic purposes, targeting areas such as immuno-oncology, autoimmune diseases, and liver disorders. The company aims to democratize disease detection and enhance life science research through innovative, affordable, and efficient tools, while also leveraging its exclusive licensing of various Cas proteins for improved diagnostics and therapeutic applications.
Opencare Inc. is a healthcare discovery platform based in Toronto, Canada, that facilitates connections between patients and healthcare providers across North America. Founded in 2012 and initially known as HealthKiwi Inc., Opencare specializes in the dental sector, creating a premium dental care network that ensures patients receive high-quality care from top dentists. The platform simplifies the process of finding and booking appointments with various healthcare providers, including dentists, chiropractors, massage therapists, physiotherapists, and optometrists. By streamlining interactions between patients and providers, Opencare aims to enhance the overall patient experience in accessing healthcare services.
Notable
Seed Round in 2018
Notable is an AI-driven platform designed to enhance healthcare operations by automating various workflows. With deployment at over 10,000 care sites, Notable automates more than a million repetitive tasks daily, including Registration and Intake, Scheduling and Referrals, and Authorizations. The platform features a voice-powered application that streamlines physician-patient interactions by structuring conversations, dictations, and orders, while also securely recommending billing codes. This automation not only facilitates personalized and efficient patient care but also alleviates the manual workload for healthcare providers, contributing to their financial health.
100Plus
Seed Round in 2018
100Plus is a rapidly growing remote patient monitoring platform designed to enhance the management of chronic patients, particularly among the elderly. The company provides an integrated solution that includes patient outreach, device setup, patient engagement, and automatic billing, all without requiring smartphones, apps, Bluetooth, or WiFi. This simplifies the process for both patients and healthcare providers. By delivering fully configured medical devices at no cost to Medicare patients or practices, 100Plus facilitates continuous monitoring of high-risk seniors, enabling healthcare professionals to proactively engage with patients. This approach aims to reduce the need for expensive episodic care and improve overall quality of life for patients.
Coral Genomics
Seed Round in 2018
Coral Genomics, Inc. is a biotechnology company founded in 2018 and headquartered in San Francisco, California. The company focuses on optimizing drug development and deployment by leveraging genomic data from patients. It specializes in developing clinical tests that assist healthcare providers in streamlining prior authorization processes and selecting effective medications tailored to individual patients, particularly in the context of autoimmune conditions like Inflammatory Bowel Disease and Rheumatoid Arthritis. Additionally, Coral Genomics has identified a distinct group of non-responder patients and collaborates with pharmaceutical developers to address the unmet medical needs of this population. By measuring cell responsiveness to drugs and understanding variability across patients, Coral Genomics aims to enhance treatment strategies and improve patient outcomes.
Maven Clinic
Series A in 2017
Maven Clinic is an on-demand digital care clinic focused on supporting mothers and families during conception, pregnancy, and the postpartum period. Founded in 2014 and headquartered in New York City, the clinic provides video appointments and private messaging with a network of women's and family health practitioners. Its comprehensive services cater to various needs, including IVF and egg-freezing tracks, pregnancy, postpartum, partner support, adoption, surrogacy, and loss. Additionally, Maven Clinic offers career coaching, support, and customized training for human resources managers. The company serves individuals, employers, and healthcare professionals, aiming to enhance family health and well-being through accessible digital care solutions.
Mammoth Biosciences
Seed Round in 2017
Mammoth Biosciences, Inc. is a biotechnology company based in South San Francisco, California, founded in 2017 by CRISPR pioneer Jennifer Doudna and other key innovators. The company specializes in developing advanced CRISPR technologies, including its proprietary DETECTR platform, which enables the rapid detection of specific nucleic acids associated with various diseases. This platform facilitates diagnostic applications such as cancer screening, bacterial infections, and viral infections, allowing for real-time and simultaneous testing of multiple conditions. In addition to diagnostics, Mammoth Biosciences works on genome editing solutions for therapeutic purposes, targeting areas such as immuno-oncology, autoimmune diseases, and liver disorders. The company aims to democratize disease detection and enhance life science research through innovative, affordable, and efficient tools, while also leveraging its exclusive licensing of various Cas proteins for improved diagnostics and therapeutic applications.
Guardant Health
Series E in 2017
Guardant Health, Inc. is a precision oncology company headquartered in Redwood City, California, specializing in liquid biopsy tests for cancer diagnosis and treatment. The company provides a range of blood tests, including Guardant360, which measures various cancer-related genes for advanced stage cancer treatment selection, and GuardantOMNI, a broader gene panel that supports immuno-oncology research. Additionally, Guardant Health offers LUNAR-1 for detecting minimal residual disease and recurrence in cancer survivors, along with the development of LUNAR-2 for early cancer detection in high-risk individuals. The company also provides development services such as companion diagnostic development and clinical trial support to biopharmaceutical firms and medical institutions. Founded in 2011, Guardant Health is recognized for its innovative approach to addressing unmet needs in oncology through advanced technology and analytics.
Blink Health LLC is a digital platform that facilitates the online purchase of prescription medications at lower prices. Founded in 2014 and headquartered in New York, the service allows users to search for their medical prescriptions and either pick them up at local pharmacies across the United States or have them delivered to their homes. By providing access to discounted medications, Blink Health aims to make prescription drugs more affordable and accessible to millions of people. Through its user-friendly web application, the company seeks to streamline the medication purchasing process, enabling customers to save both time and money.
uBiome, Inc. was a microbial genomics company based in San Francisco, California, founded in 2012. It specialized in sequencing-based clinical microbiome tests, offering products such as SmartGut, a test for identifying pathogenic and commensal microorganisms related to infections, and SmartJane, a women's health screening test that detects various conditions including HPV and STIs. The company also provided Explorer kits for citizen scientists and researchers, as well as SmartFlu, a clinical respiratory test. By leveraging precision sequencing combined with machine learning and artificial intelligence, uBiome aimed to enhance the understanding of the human microbiome, enabling healthcare providers to deliver more accurate diagnoses and empowering patients to manage their health more effectively. However, uBiome faced financial difficulties and filed for Chapter 11 bankruptcy in September 2019, which was later converted to Chapter 7 on October 11, 2019.
Medal, Inc. is a healthcare company based in San Francisco, California, that specializes in providing administrator services. Established in 2015, the company focuses on the extraction, transportation, translation, and sharing of medical information. Medal’s services facilitate the efficient review, coordination, referral, analysis, billing, and auditing of healthcare data. As of July 2020, Medal operates as a subsidiary of CIOX Health, enhancing its capabilities in the healthcare information management sector.
Blink Health LLC is a digital platform that facilitates the online purchase of prescription medications at lower prices. Founded in 2014 and headquartered in New York, the service allows users to search for their medical prescriptions and either pick them up at local pharmacies across the United States or have them delivered to their homes. By providing access to discounted medications, Blink Health aims to make prescription drugs more affordable and accessible to millions of people. Through its user-friendly web application, the company seeks to streamline the medication purchasing process, enabling customers to save both time and money.
Maven Clinic
Seed Round in 2016
Maven Clinic is an on-demand digital care clinic focused on supporting mothers and families during conception, pregnancy, and the postpartum period. Founded in 2014 and headquartered in New York City, the clinic provides video appointments and private messaging with a network of women's and family health practitioners. Its comprehensive services cater to various needs, including IVF and egg-freezing tracks, pregnancy, postpartum, partner support, adoption, surrogacy, and loss. Additionally, Maven Clinic offers career coaching, support, and customized training for human resources managers. The company serves individuals, employers, and healthcare professionals, aiming to enhance family health and well-being through accessible digital care solutions.
RondinX
Seed Round in 2016
Founded in 2015 by leading microbiome experts, RondinX specializes in the development of an advanced drug discovery platform focused on microbiome therapeutics and companion diagnostics. The company employs a unique cloud-based computational pipeline known as the PTR (Peak-to-Trough) family of algorithms, which generates both static and dynamic insights into the bacterial ecosystem. This innovative technology aims to facilitate the discovery of targeted therapeutic solutions in the microbiome space, positioning RondinX as a key player in addressing emerging needs in healthcare related to microbiome-related conditions.